Hormone-modulating therapy may reduce dementia risk in breast cancer
Jul 25, 2024
The greatest reduction was seen for women aged 65 to 74 years who self-identify as Black.
Communities break fundraising record during The Longest Day
By
Foster Stubbs
Jul 24, 2024
63 Charter Senior Living communities across the nation raised money for Alzheimer’s research as part of the Alzheimer’s Association’s The Longest Day initiative. Find out more, and learn how to submit...
Dementia rate decline accelerates during COVID-19 pandemic
By
Eliza Mattson
Jul 23, 2024
Before the COVID-19 pandemic, the rate of older adults living with dementia was decreasing. The pandemic accelerated that decline, however, due to an increase in deaths among older adults living with dementia,...
Increasing RN staffing hours reduces injury-related ED visits by assisted living residents with dementia:...
By
Kimberly Bonvissuto
Jul 19, 2024
A new study found that increasing staffing hours of registered nurses in assisted living communities led to a 53% decrease in injury-related emergency department visits by residents living with Alzheimer’s...
Benzodiazepines not tied to higher dementia risk in older adults
Jul 16, 2024
Potential class-dependent associations may exist, however.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
More news for Monday, July 15
By
Kimberly Bonvissuto
Jul 15, 2024
CMS releases companion guide to Medicaid Access Rule … Racial disparities in dementia determined by social factors, not genetics … Addressing loneliness over time may play important role in stroke...
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
Senior living providers embrace role in CMS dementia care pilot program
By
Kimberly Bonvissuto
Jul 11, 2024
Senior living providers named participants in the federal government’s new dementia care pilot program said they are excited to be part of a new effort to support people living with dementia and their...
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...